ATE511651T1 - Transglutaminase 6 als diagnostischer indikator für autoimmunerkrankungen - Google Patents

Transglutaminase 6 als diagnostischer indikator für autoimmunerkrankungen

Info

Publication number
ATE511651T1
ATE511651T1 AT07007262T AT07007262T ATE511651T1 AT E511651 T1 ATE511651 T1 AT E511651T1 AT 07007262 T AT07007262 T AT 07007262T AT 07007262 T AT07007262 T AT 07007262T AT E511651 T1 ATE511651 T1 AT E511651T1
Authority
AT
Austria
Prior art keywords
transglutaminase
autoimmune diseases
diagnostic indicator
novel antigen
diagnostic
Prior art date
Application number
AT07007262T
Other languages
English (en)
Inventor
Daniel Aeschlimann
Marios Hadjivassilliou
Original Assignee
Zedira Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zedira Gmbh filed Critical Zedira Gmbh
Application granted granted Critical
Publication of ATE511651T1 publication Critical patent/ATE511651T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1025—Acyltransferases (2.3)
    • C12N9/104—Aminoacyltransferases (2.3.2)
    • C12N9/1044—Protein-glutamine gamma-glutamyltransferase (2.3.2.13), i.e. transglutaminase or factor XIII
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/91—Transferases (2.)
    • G01N2333/91045—Acyltransferases (2.3)
    • G01N2333/91074—Aminoacyltransferases (general) (2.3.2)
    • G01N2333/9108—Aminoacyltransferases (general) (2.3.2) with definite EC number (2.3.2.-)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/06—Gastro-intestinal diseases
    • G01N2800/065—Bowel diseases, e.g. Crohn, ulcerative colitis, IBS
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/24—Immunology or allergic disorders
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT07007262T 2007-04-06 2007-04-06 Transglutaminase 6 als diagnostischer indikator für autoimmunerkrankungen ATE511651T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP07007262A EP1978364B1 (de) 2007-04-06 2007-04-06 Transglutaminase 6 als diagnostischer Indikator für Autoimmunerkrankungen

Publications (1)

Publication Number Publication Date
ATE511651T1 true ATE511651T1 (de) 2011-06-15

Family

ID=38158045

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07007262T ATE511651T1 (de) 2007-04-06 2007-04-06 Transglutaminase 6 als diagnostischer indikator für autoimmunerkrankungen

Country Status (7)

Country Link
US (1) US20130196336A1 (de)
EP (1) EP1978364B1 (de)
AT (1) ATE511651T1 (de)
AU (1) AU2008234999A1 (de)
CA (1) CA2683394A1 (de)
RU (1) RU2009140980A (de)
WO (1) WO2008122432A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU0900199D0 (en) * 2009-04-01 2009-06-29 Debreceni Egyetem Diagnosis of gluten-induced autoimmune diseases
HU0900195D0 (en) * 2009-04-01 2009-06-29 Debreceni Egyetem Diagnosis and treatment of gluten-induced autoimmune diseases
EP2322926A1 (de) * 2009-11-11 2011-05-18 Zedira GmbH Stabilisiertes Transglutaminase als diagnostischer Indikator für Autoimmunerkrankungen
ES2602628T3 (es) * 2009-11-11 2017-02-21 Zedira Gmbh Transglutaminasa de forma abierta estabilizada como indicador diagnóstico para enfermedades auto-immunes
CN103154736B (zh) 2010-05-13 2016-04-06 新泽西医科和牙科大学 用于检测和诊断神经变性疾病的诊断性自身抗体谱
CN102220337B (zh) * 2010-09-19 2012-11-14 中南大学 一种遗传性脊髓小脑共济失调相关基因
WO2013010003A1 (en) 2011-07-12 2013-01-17 University Of Medicine And Dentistry Of New Jersey Diagnostic biomarker profiles for the detection and diagnosis of alzheimer's disease
EP3260864A1 (de) * 2016-06-21 2017-12-27 Euroimmun Medizinische Labordiagnostika AG Diagnostischer co-inkubations-assay
IT202100019616A1 (it) * 2021-07-23 2023-01-23 Univ Degli Studi Di Trieste Nuovo metodo
CN116515786B (zh) * 2023-04-26 2024-05-28 广东医科大学 一种人tgm3乙酰化多肽、抗原、抗体及其制备方法和应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19630557C2 (de) 1996-07-18 1998-07-02 Schuppan Detlef Priv Doz Dr Dr Verfahren zum Nachweis von Antikörpern aus Körperflüssigkeiten durch eine Immunreaktion mit Gewebe-Transglutaminase (tTG) sowie die Verwendung von tTG in Diagnose und Therapie
ATE269543T1 (de) 1999-06-28 2004-07-15 Immundiagnostik Ag Diagnose der glutensensibilitätsenteropathie und anderer autoimmunerkrangungen
US7052890B2 (en) 2000-09-15 2006-05-30 University College Cardiff Consultants, Ltd. Transglutaminase gene products
GB0103024D0 (en) * 2001-02-07 2001-03-21 Rsr Ltd Assay for Autoantibodies to tissue transglutaminase

Also Published As

Publication number Publication date
EP1978364A1 (de) 2008-10-08
WO2008122432A1 (en) 2008-10-16
AU2008234999A1 (en) 2008-10-16
US20130196336A1 (en) 2013-08-01
RU2009140980A (ru) 2011-05-20
EP1978364B1 (de) 2011-06-01
CA2683394A1 (en) 2008-10-16

Similar Documents

Publication Publication Date Title
ATE511651T1 (de) Transglutaminase 6 als diagnostischer indikator für autoimmunerkrankungen
EA201100231A1 (ru) Диагностический анализ на основе антител
WO2011142827A3 (en) Diagnostic markers for neuropsychiatric disease
CA2839777C (en) Methods for the prognostic and/or diagnostic of neurodegenerative disease, methods to identify candidate compounds and compounds for treating neurodegenerative disease
DK1974210T3 (da) Fremgangsmåde til diagnosticering af polycystisk nyresygdom
EP3070474A3 (de) Verfahren und zusammensetzungen zur diagnose und prognose von nierenläsion und niereninsuffizienz
DE602006007703D1 (de) Verbesserte immuntestverfahren
BR112014013082A2 (pt) método para detectar adutos nucleossomos
EP2579038A3 (de) Biomarker für multiple Sklerose
WO2015157407A8 (en) Small molecule biochemical profiling of individual subjects for disease diagnosis and health assessment
AR054479A1 (es) Metodo para diagnosticar l a enfermedad de alzheimer
WO2008131039A3 (en) Cardibioindex/cardibioscore and utility of salivary proteome in cardiovascular diagnostics
WO2008148072A3 (en) Disease-associated genetic variations and methods for obtaining and using same
EA201001874A1 (ru) Способ диагностики злокачественных новообразований, экспрессирующих рецептор her2 или его укороченные варианты
EP2261367A3 (de) Expressionsmarker für entzündliche darmkrankheiten
NO20070949L (no) Transkriptomdiagnostikk i spytt
WO2009083950A3 (en) Biomarkers for the prediction of renal injury
GT200600286A (es) Diagnostico de artritis reumatoide por imagenes opticas
WO2010041149A3 (en) Methods and compositions for diagnosis and treatment of autoimmune disease secondary to multiple sclerosis
FR2964744B1 (fr) Test pronostic de l'evolution d'une tumeur solide par analyse d'images
WO2012122374A3 (en) Non-invasive methods for diagnosing chronic organ transplant rejection
DK2021794T3 (da) Anvendelse af protein S100A 12 som en markør for colorektal cancer
ATE451475T1 (de) Verfahren und systeme zur diagnose von nicht das zentrale nervensystem (zns) betreffenden krankheiten in zns-proben
BR112015014232A2 (pt) lesão renal aguda
WO2006099543A3 (en) Methods for assessing antibody-mediated cytotoxicity

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties